NasdaqCM - Delayed Quote USD

ClearPoint Neuro, Inc. (CLPT)

5.32 -0.18 (-3.27%)
At close: April 24 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
23,955.00
23,955.00
20,551.00
16,299.00
12,829.00
Cost of Revenue
10,341.00
10,341.00
7,020.00
5,176.00
3,709.00
Gross Profit
13,614.00
13,614.00
13,531.00
11,123.00
9,120.00
Operating Expense
36,060.00
36,060.00
29,863.00
24,497.00
15,340.00
Operating Income
-22,446.00
-22,446.00
-16,332.00
-13,374.00
-6,220.00
Net Non Operating Interest Income Expense
386.00
386.00
-81.00
-973.00
-1,444.00
Other Income Expense
-29.00
-29.00
-22.00
-63.00
882.00
Pretax Income
-22,089.00
-22,089.00
-16,435.00
-14,410.00
-6,782.00
Net Income Common Stockholders
-22,089.00
-22,089.00
-16,435.00
-14,410.00
-6,782.00
Diluted NI Available to Com Stockholders
-22,089.00
-22,089.00
-16,435.00
-14,410.00
-6,782.00
Basic EPS
-0.90
--
-0.68
-0.69
-0.43
Diluted EPS
-0.90
--
-0.68
-0.69
-0.43
Basic Average Shares
24,605.21
--
24,181.85
20,734.24
15,849.67
Diluted Average Shares
24,605.21
--
24,181.85
20,734.24
15,849.67
Total Operating Income as Reported
-22,446.00
-22,446.00
-16,332.00
-13,374.00
-6,220.00
Total Expenses
46,401.00
46,401.00
36,883.00
29,673.00
19,049.00
Net Income from Continuing & Discontinued Operation
-22,089.00
-22,089.00
-16,435.00
-14,410.00
-6,782.00
Normalized Income
-22,089.00
-22,089.00
-16,435.00
-14,410.00
-6,782.00
Interest Income
386.00
386.00
--
--
--
Interest Expense
--
--
81.00
973.00
1,444.00
Net Interest Income
386.00
386.00
-81.00
-973.00
-1,444.00
EBIT
-22,446.00
-22,446.00
-16,354.00
-13,437.00
-5,338.00
EBITDA
-20,989.00
-20,989.00
-15,577.00
-12,745.00
-4,788.00
Reconciled Cost of Revenue
10,341.00
10,341.00
7,020.00
5,176.00
3,709.00
Reconciled Depreciation
1,457.00
1,457.00
777.00
692.00
550.00
Net Income from Continuing Operation Net Minority Interest
-22,089.00
-22,089.00
-16,435.00
-14,410.00
-6,782.00
Normalized EBITDA
-20,989.00
-20,989.00
-15,577.00
-12,745.00
-4,788.00
12/31/2020 - 5/22/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MXCT MaxCyte, Inc.
3.7400
-1.58%
 
ELMD Electromed, Inc.
16.73
+2.07%
 
TMDX TransMedics Group, Inc.
88.88
-1.90%
 
CVRX CVRx, Inc.
14.40
+0.77%
 
AXGN AxoGen, Inc.
6.87
-1.43%
 
OM Outset Medical, Inc.
2.5500
+3.66%
 
CLS-B.ST Clinical Laserthermia Systems AB (publ)
19.25
+2,927.45%
 
DCTH Delcath Systems, Inc.
5.45
-2.68%
 
LNSR LENSAR, Inc.
3.2600
+2.52%
 
SSKN STRATA Skin Sciences, Inc.
0.5600
+3.70%